CA2106695A1 - Acide hyaluronique et composes pour la prevention de la restenose arterielle - Google Patents

Acide hyaluronique et composes pour la prevention de la restenose arterielle

Info

Publication number: CA2106695A1
Authority: CA; Canada
Prior art keywords: hyaluronic acid; forms; arterial restenosis; prevent arterial; tubular walls
Prior art date: 1993-09-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA2106695A

Other languages

English (en)

Other versions

CA2106695C (fr

Inventor

Rudolf Edgar Falk

Samuel Simon Asculai

Eva Anne Turley

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Jagotec AG

Original Assignee

Hyal Pharmaceutical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-22

Filing date

1993-09-22

Publication date

1995-03-23

1993-09-22 Application filed by Hyal Pharmaceutical Corp filed Critical Hyal Pharmaceutical Corp

1993-09-22 Priority to CA002106695A priority Critical patent/CA2106695C/fr

1995-03-23 Publication of CA2106695A1 publication Critical patent/CA2106695A1/fr

2000-01-18 Application granted granted Critical

2000-01-18 Publication of CA2106695C publication Critical patent/CA2106695C/fr

2013-09-22 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
229920002674 hyaluronan Polymers 0.000 title abstract 3
229960003160 hyaluronic acid Drugs 0.000 title abstract 3
206010051113 Arterial restenosis Diseases 0.000 title 1
150000002148 esters Chemical class 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

CA002106695A 1993-09-22 1993-09-22 Acide hyaluronique et composes pour la prevention de la restenose arterielle Expired - Lifetime CA2106695C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA002106695A CA2106695C (fr)	1993-09-22	1993-09-22	Acide hyaluronique et composes pour la prevention de la restenose arterielle

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002106695A CA2106695C (fr)	1993-09-22	1993-09-22	Acide hyaluronique et composes pour la prevention de la restenose arterielle

Publications (2)

Publication Number	Publication Date
CA2106695A1 true CA2106695A1 (fr)	1995-03-23
CA2106695C CA2106695C (fr)	2000-01-18

Family

ID=4152348

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002106695A Expired - Lifetime CA2106695C (fr)	1993-09-22	1993-09-22	Acide hyaluronique et composes pour la prevention de la restenose arterielle

Country Status (1)

Country	Link
CA (1)	CA2106695C (fr)

1993
- 1993-09-22 CA CA002106695A patent/CA2106695C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2106695C (fr)	2000-01-18

Similar Documents

Publication	Publication Date	Title
EP0773029A4 (fr)	1997-09-03	Inhibiteur de proliferation du virus de l'hepatite c
RU95101048A (ru)	1996-10-27	Производные пролинамида, фармкомпозиция на их основе
HUT61989A (en)	1993-03-29	Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient
CA2120942A1 (fr)	1994-03-03	Esters nitriques de derives de l'acide 2-(2,6-dihalophenylamino)phenylacetique et methode pour les preparer
DE69508463D1 (de)	1999-04-29	Propiophenonderivate und Verfahren zu deren Herstellung
CA2140106A1 (fr)	1995-07-14	Methode de traitement des affections vasculaires hyperproliferatives
CA2356380A1 (fr)	2000-07-06	Effets immunosuppresseurs de derives de la pteridine
ATE121295T1 (de)	1995-05-15	Augentropfenarzneimittel.
CA2233315A1 (fr)	1997-04-17	Compositions pharmaceutiques contenant des derives d'acide hydroximique
EP0773022A3 (fr)	1999-05-12	Composition pharmaceutique pour le traitement de la rhinite, contenant un sympathomimétique et du pantothenol et/ou l'acide pantothénique
EP0350840A3 (fr)	1991-11-06	Agent antiviral
CA2079205A1 (fr)	1994-03-26	Utilisation de l'acide hyaluronique et de formules pour empecher la restenose arterielle
IL90056A (en)	1993-04-04	Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
HUT50334A (en)	1990-01-29	Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
NZ248227A (en)	1995-09-26	2-phenylacrylic acid ester derivatives, fungicidal compositions thereof
FR2681863B1 (fr)	1995-02-03	Solution de sparfloxacine sa preparation et sel la constituant.
CA2106695A1 (fr)	1995-03-23	Acide hyaluronique et composes pour la prevention de la restenose arterielle
HUT54166A (en)	1991-01-28	Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
EP0285871A3 (en)	1989-12-13	Sustained release granulate without binding agent
CA2120045A1 (fr)	1995-09-26	Utilisation d'acide hyaluronique et de ses derives dans la prevention de la restenose arterielle
WO1990003172A3 (fr)	1990-06-28	Acides biliaires de traitement d'infections virales
PT855398E (pt)	2003-07-31	Derivados sasquiterpeno tendo actividade antiviral
CA2065889A1 (fr)	1993-04-03	Augmentation du debit choroidien
CA2190952A1 (fr)	1995-12-14	Inhibition des infections retrovirales par administration de composes de l'acide naphtalene sulfonique
NZ226696A (en)	1991-10-25	Tablet composition comprising a phthalazine acetic acid derivative as the active ingredient present in from 83-88 wt%

Legal Events

Date	Code	Title	Description
1993-09-22	EEER	Examination request